WebCyclophosphamide, also called Cytoxan, is classified as a “cytotoxic agent”, because it has a toxic effect on many types of cells (“good” cells as well as “bad”). … WebDec 3, 2016 · Cytoxan treatments - Pulmonary fibrosis. Inspire Living with Pulmonary Fibrosis Medications for PF.
Interstitial Lung Disease: Pulmonary Fibrosis - Johns Hopkins Medicine
WebJan 5, 2024 · Interstitial lung disease is characterised by a combination of cellular proliferation, inflammation of the interstitium and fibrosis within the alveolar wall. A 58-year-old man was referred for lung transplantation after developing worsening dyspnoea and progressive hypoxaemic respiratory failure from idiopathic pulmonary fibrosis. Three … WebApr 12, 2024 · Reversible inflammatory disease predominates in a minority of patients but in most cases, prevention of progression of pulmonary fibrosis is the most realistic therapeutic goal. Routine first-line treatment largely consists of immunosuppressive therapy, based on two controlled trials of cyclophosphamide and a comparison between … dfw housecall physicians dallas tx
UpToDate
WebMay 8, 2024 · Pulmonary artery hypertension occurs due to vasculopathy, as well as a loss of pulmonary microvasculature due to progressive pulmonary fibrosis. Renal involvement has become less frequent. … WebFeb 23, 2024 · Possible conditions include pneumonitis (inflammation of lung tissue), pulmonary fibrosis (lung diseases that cause tissue to become damaged and scarred), … WebCyclophosphamide (Cytoxan) was developed as a chemotherapeutic agent to treat cancer. It is also used as an antirejection medication for organ transplants. ... Other severe side effects include an increased future risk of cancer, infertility, allergic reactions, and pulmonary fibrosis. Cyclophosphamide is given orally or intravenously. The oral ... dfw house call physicians